These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1961870)

  • 21. Definition and functions of natural killer cells.
    Lotzová E
    Nat Immun; 1993; 12(4-5):169-76. PubMed ID: 8257824
    [No Abstract]   [Full Text] [Related]  

  • 22. Sources of confounding in immunologic data.
    Herberman RB
    Rev Infect Dis; 1991; 13 Suppl 1():S84-6. PubMed ID: 2020807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cell cytotoxicity and lymphocyte perforin expression in veterans with posttraumatic stress disorder.
    Gotovac K; Vidović A; Vukusić H; Krcmar T; Sabioncello A; Rabatić S; Dekaris D
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):597-604. PubMed ID: 20184935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The choices of a natural killer.
    Trinchieri G
    Nat Immunol; 2003 Jun; 4(6):509-10. PubMed ID: 12774071
    [No Abstract]   [Full Text] [Related]  

  • 25. Allorecognition by murine natural killer cells: studies with bone marrow transplants and lysis of T lymphoblasts.
    Liu J; Yu YY; Lindahl KF; Kumar V; Bennett M
    Chem Immunol; 1996; 64():164-80. PubMed ID: 8942079
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of adherent cells in supporting natural cytotoxicity reactions].
    Sorokin AM; Chenëv SB; Koval'chuk LV
    Biull Eksp Biol Med; 1989 Sep; 108(9):322-5. PubMed ID: 2611391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies of the mechanism of disorders of the natural killer cell activity in patients with systemic scleroderma].
    Rudnicka L; Majewski S; Błaszczyk M; Skiendzielewska A; Makieła B
    Przegl Dermatol; 1990; 77(4):252-4. PubMed ID: 2267353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activity of natural killer cells of peripheral blood in patients with rheumatoid arthritis and their clinical significance].
    Satybaldyev AM; Riazantseva TA; Speranskiĭ AI
    Revmatologiia (Mosk); 1991; (4):17-9. PubMed ID: 1805325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Now you see it, now you don't!
    Yokoyama WM
    Nat Immunol; 2000 Aug; 1(2):95-7. PubMed ID: 11248795
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunomodulating properties of opioids].
    Członkowski A; Kotapski J
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):100-2. PubMed ID: 2170957
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation of self-ligands for activating natural killer cell receptors.
    Lam RA; Chwee JY; Le Bert N; Sauer M; Pogge von Strandmann E; Gasser S
    Ann Med; 2013 Jun; 45(4):384-94. PubMed ID: 23701136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection.
    Varchetta S; Mele D; Mantovani S; Oliviero B; Cremonesi E; Ludovisi S; Michelone G; Alessiani M; Rosati R; Montorsi M; Mondelli MU
    Hepatology; 2012 Sep; 56(3):841-9. PubMed ID: 22431186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens.
    Dao T; Gomez-Nunez M; Antczak C; Kappel B; Jaggi JS; Korontsvit T; Zakhaleva V; Scheinberg DA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8763-72. PubMed ID: 16361564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of polysialylated CD56 on natural killer cell cytotoxicity.
    Moebius JM; Widera D; Schmitz J; Kaltschmidt C; Piechaczek C
    BMC Immunol; 2007 Aug; 8():13. PubMed ID: 17683591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological aspects of pathophysiology of chronic fatigue syndrome].
    Matsumoto Y
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Jun; 22(3):111-22. PubMed ID: 11126662
    [No Abstract]   [Full Text] [Related]  

  • 37. Cortisol deficiency may account for elevated apoptotic cell population in patients with chronic fatigue syndrome.
    Baschetti R
    J Intern Med; 1999 Apr; 245(4):409-10. PubMed ID: 10356605
    [No Abstract]   [Full Text] [Related]  

  • 38. Effector pathways of natural killer cells.
    Van den Broek MF; Kägi D; Hengartner H
    Curr Top Microbiol Immunol; 1998; 230():123-31. PubMed ID: 9586354
    [No Abstract]   [Full Text] [Related]  

  • 39. Motivational syndromes associated with natural killer cell activity.
    Jemmott JB; Hellman C; McClelland DC; Locke SE; Kraus L; Williams RM; Valeri CR
    J Behav Med; 1990 Feb; 13(1):53-73. PubMed ID: 2348449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of deviant immunological test values in chronic fatigue syndrome patients.
    Natelson BH; Ellis SP; Braonáin PJ; DeLuca J; Tapp WN
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):238-40. PubMed ID: 7697537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.